Chemoembolization in Patients with Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 1, Iss. 1, 2012-06 ,pp. : 41-50

Karger

Access to resources Recommend Favorite

Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization

By Kim Jeong Han   Kim Ji Hoon   Choi Jong Hwan   Kim Chung Ho   Jung Young Kul   Yim Hyung Joon   Yeon Jong Eun   Park Jong-Jae   Kim Jae Seon   Bak Young-Tae   Byun Kwan Soo  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 3, 2009-03 ,pp. : 346-357

Informa Healthcare

Access to resources Recommend Favorite

Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry

By  

Liver Cancer, Vol. 5, Iss. 1, 2016-0 ,pp. : 37-46

Karger

Access to resources Recommend Favorite

The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization

By  

Liver Cancer, Vol. 6, Iss. 3, 2017-05 ,pp. : 227-235

Karger

Access to resources Recommend Favorite

Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma

By Sinakos Emmanouil   Dedes Ioannis   Papalavrentios Lavrentis   Drevelegas Antonios   Akriviadis Evangelos  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 4, 2010-04 ,pp. : 511-512

Informa Healthcare

Access to resources Recommend Favorite